Comparison of fecal occult blood tests for colorectal cancer screening in an alaska native population with high prevalence of Helicobacter pylori infection, 2008-2012

Preventing Chronic Disease

Volumn 11, Issue 4, 2014, Pages

  Redwood, Diana ^a   Provost, Ellen ^b   Asay, Elvin ^b   Roberts, Diana ^c   Haverkamp, Donald ^c   Perdue, David ^d   Bruce, Michael G ^c   Sacco, Frank ^b   Espey, David ^c  

^a Alaska Native Tribal Health Consortium ^*  (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d American Indian Cancer Foundation and Minnesota Gastroenterology PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMERICAN INDIAN; CHEMISTRY; COLORECTAL NEOPLASMS; COMPLICATION; EARLY DIAGNOSIS; FECES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; OCCULT BLOOD; PROCEDURES; UNITED STATES;

ADULT; ALASKA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; OCCULT BLOOD;

EID: 84898845318     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd11.130281     Document Type: Article

References (31)

1. Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007;ll0(l0):2ll9-52.
2. Surveillance, Epidemiology, and End Results (SEER)*Stat Database: Mortality-All COD, Aggregated With State, Total U.S. (1990-2008) Katrina/Rita Population Adjustments National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. 2011. http://www.seer.cancer.gov. Accessed August 13, 2012.
3. Kelly JJ, Alberts SR, Sacco F, Lanier AP. Colorectal cancer in Alaska Native people, 2005-2009. Gastrointest Cancer Res 20l2;5(5):l49-54.
4. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58(3):l30-60.
5. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19 (3):449-90.
6. Yip R, Limburg PJ, Ahlquist DA, Carpenter HA, O'Neill A, Kruse D, et al. Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA l997;277(l4):ll35-9.
7. Parkinson AJ, Gold BD, Bulkow L, Wainwright RB, Swaminathan B, Khanna B, et al. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol 2000;7(6):885-8.
8. Ballew C, Ross Tzilkowski A, Hamrick K, Nobmann ED. The contribution of subsistence foods to the total diet of Alaska Natives in 13 rural communities. Ecol Food Nutr 2006;45(l):l-26.
9. Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Aliment Pharmacol Ther 2006;23(9):l359-64. Erratum in Aliment Pharmacol Ther 2006;24(5):895.
10. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 20065107(9):2l52-9.
11. Trajman A, Luiz RR. McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest 2008;68(l):77-80.
12. Hawass NE. Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients. Br J Radiol 1997570(832) :36o-6.
13. Haverkamp D, Perdue DG, Espey D, Cobb N. A survey of Indian Health Service and tribal health providers' colorectal cancer screening knowledge, perceptions, and practices. J Health Care Poor Underserved 2011;22 (l):243-57.
14. Cheng TI, Wong JM, Hong CF, Cheng SH, Cheng TJ, Shieh MJ, et al. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc 2002;101 (l0):685-90.
15. Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000;95 (5) :l33l-8.
16. Hoepffner N, Shastri YM, Hanisch E, Rosch W, Mossner J, Caspary WF, et al. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study. Aliment Pharmacol Ther 2006;23(1):145-54.
17. Nakama H, Fattah A, Zhang B, Uehara Y, Wang C. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps. Hepatogastroenterology 2000547(32) :386-9.
18. Rozen P, Knaani J, Papo N. Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia. Eur J Cancer Prev 199554(6) :475-8l.
19. Young GP, St John DJ, Cole SR, Bielecki BE, Pizzey C, Sinatra MA, et al. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J Med Screen 2003;l0(3):l23-8.
20. Chiang TH, Lee YC, Tu CH, Chiu HM, Wu MS. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ 20ll;l83(l3):l474-8l.
21. Redwood D, Provost E, Perdue D, Haverkamp D, Espey D. The last frontier: innovative efforts to reduce colorectal cancer disparities among the remote Alaska Native population. Gastrointest Endosc 2012;75(3):474-80.
22. Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FK, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology 2004;l27(6):l66l-9.
23. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000;22(2):283-97.
24. Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol 20l2;l75(l):54-9.
25. Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Effective clinical practice. Err Clin Pract 200154(4):150-6.
26. Joseph A. Compliance with fecal occult blood testing: the role of restrictive diets. Am J Public Health 1988;78 (7): 839-41.
27. Bersamin A, Zidenberg-Cherr S, Stern JS, Luick BR. Nutrient intakes are associated with adherence to a traditional diet among Yup'ik Eskimos living in remote Alaska Native communities: the CANHR Study. Int J Circumpolar Health 2007; 66(1): 62-70.
28. Redwood DG, Ferucci ED, Schumacher MC, Johnson JS, Lanier AP, Helzer LJ, et al. Traditional foods and physical activity patterns and associations with cultural factors in a diverse Alaska Native population. Int J Circumpolar Health 2008;67(4):335-48.
29. Indian Health Service. Alaska area aggregate GPRA [Government Performance and Results Act of 1993] clinical performance report, CRS [Clinical Reporting System] Version 10.0. Anchorage (AK): Alaska Area Native Health Service; 2012.
30. Kluhsman BC, Lengerich EJ, Fleisher L, Paskett ED, Miller-Halegoua SM, Balshem A, et al. A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009. Prev Chronic Dis 2012;9:E77.
31. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 20l2;366(8):697-706.